A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. (Q45251395)
Jump to navigation
Jump to search
scientific article published on 3 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. |
scientific article published on 3 February 2005 |
Statements
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival (English)
Azra J Alvi
Belinda Austen
Victoria J Weston
Christopher Fegan
David MacCallum
Athos Gianella-Borradori
Judith E Powell
A Malcolm R Taylor